GlassScriptPhysician profile
Thomas Anthony Olexa
NPI 1144201088
$4,945.63
in general payments reported to CMS, 2019-2025
12 companies · $2,031 in 2025
The $2,031 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,021 · 2020: $30.06 · 2021: $1,222 · 2022: $364 · 2023: $65.78 · 2024: $213 · 2025: $2,031.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,617 · Food and Beverage: $693.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,616.64 |
| Food and Beverage | $692.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rock Medical Orthopedics, INC. | $1,780.54 | 2021-2024 | |
| Arthrex, INC. | $1,062.90 | 2019-2025 | |
| Cdc Medical LLC | $922.78 | 2019 | |
| Nexus Medical Technologies LLC | $878.28 | 2025 | |
| Vericel Corporation | $57.74 | 2023-2025 | Maci |
| Smith+Nephew, INC. | $47.54 | 2019-2020 | |
| Depuy Synthes Sales INC. | $45.49 | 2023 | Na |
| Amgen INC. | $43.44 | 2025 | Evenity |
| Breg, INC | $33.17 | 2019 | |
| Axogen | $31.25 | 2025 | |
| Radius Health, INC. | $23.15 | 2025 | Tymlos |
| Ferring Pharmaceuticals INC. | $19.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Olexa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.